Modern Age Tirzepatide Review: Assessment Fees & Medication Expenses

Modern Age is an assessment-heavy care option with Mounjaro listed among possible prescriptions. Its public page separates a $500 Aging Wellness Assessment, a further $500 six-month Optimization Program and the cost of medication.¹

Our view: this is a service to compare for the wider evaluation and follow-up, not a low-price tirzepatide package. The assessment and program together represent $1,000 before medication, and the actual prescription still depends on clinical judgment.

What the price actually covers

The page estimates uncovered GLP-1 medication at $900–1,600 monthly. That is a provider estimate across named treatments, not a current pharmacy quote for your specific Mounjaro prescription. Ask the pharmacy to price the exact product and supply before judging affordability.¹

The six-month care program's $500 fee should also be kept separate from any monthly medication expense. Ask when the assessment and program charges are collected, whether insurance can cover any services and whether you must buy the assessment before learning if the clinician will consider tirzepatide. If testing has already been done elsewhere, ask whether those results can be accepted.

Care, prescription and pharmacy access

Modern Age describes a broad assessment, review of biomarkers and monthly 15-minute follow-up appointments in the Optimization Program. It offers virtual or in-person check-ins and insurance coordination through an unnamed pharmacy partner.¹

A broad evaluation may be useful if you want to discuss more than weight alone. Consider whether a short monthly follow-up gives enough time for the issues you want covered, and ask how questions between appointments are handled. The publicly described assessment should not be taken as proof that every listed test is needed for every patient.

Cancellation and practical limits

The page says the Weight Loss Program can be refunded until the first GLP-1 or metformin prescription is purchased through its pharmacy partner. It does not offer program refunds afterward for medication expense, side effects or other factors.¹ Ask whether that statement applies to the separate assessment fee and how to request cancellation before the cutoff.

The page contains imprecise wording about the forms of several named drugs. Mounjaro is the tirzepatide option listed; semaglutide and metformin are different medications. Ask the clinician which product is proposed, its intended indication and the fulfillment route. Do not transfer general marketing claims about the entire catalog to one prescription.

What the six-month program buys

The program describes monthly fifteen-minute follow-ups. Over six months, that cadence implies six follow-up opportunities if they occur monthly as described, but the exact booking schedule should be confirmed. Ask whether missed appointments can be rescheduled, whether messages between visits are included and what happens if the medication changes. The $500 program fee is meaningful only in relation to that actual access.¹

The assessment and care program total $1,000 before any prescription is purchased. Spreading that over six months gives about $166.67 per month as a comparison of those two service charges; it is not Modern Age's payment schedule and excludes the drug. The separate medication estimate is broad enough that a real pharmacy quote remains essential.

The refund trigger also creates a decision point after evaluation but before the first prescription purchase. Ask for time to review the pharmacy price and the clinician's recommendation before crossing that point. A reader who wants broader aging-health assessment may value the package, while someone seeking only affordable continuing prescribing may find the additional evaluation difficult to justify.

How it compares

Compare Marek Health for a lab-centered program and Steady State Health for a regional midlife-care focus. Separate the value of a wider assessment from the price of a specific medication, since the same prescription does not imply the same care package.

The tirzepatide-versus-semaglutide comparison separates several drugs named on the page. Review the dosing overview with your clinician, and use the Zepbound cost guide specifically for branded tirzepatide pricing context rather than applying a general GLP-1 estimate.

Prescription suitability is a clinical decision. The Mounjaro prescribing information describes important risks and contraindications; discuss your complete medical history and medication list before treatment.⁴

Our assessment

Modern Age is an expensive entry point if your goal is only a prescription. Its wider assessment may appeal for other reasons, but the separate $500 assessment, $500 care program and medication bill should each have a clear purpose in your decision.